Use of rituximab in chronic childhood immune thrombocytopenic purpura

Pediatrics International

Volumn 48, Issue 5, 2006, Pages 514-516

  Bay, Ali ^a   Öner, Ahmet Faik ^a   Uner, Abdurrahman ^a   Dogan, Murat ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Child; Immune thrombocytopenic purpura; Rituximab

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; RHESUS D ANTIBODY; RITUXIMAB;

ADOLESCENT; ARTICLE; BLEEDING; BLOOD CELL COUNT; CASE REPORT; CHILDHOOD DISEASE; CHRONIC DISEASE; DRUG MEGADOSE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOGLOBULIN BLOOD LEVEL; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REFRACTORY PERIOD; SCHOOL CHILD; SIDE EFFECT;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHILD; CHRONIC DISEASE; DRUG RESISTANCE; FEMALE; HUMANS; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 33748674415     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2006.02251.x     Document Type: Article

References (10)

1. Tarantino MD. Treatment options for chronic immune (idiopathic) thrombocytopenic purpura in children. Semin. Hematol. 2000; 37: 35-41.
2. Bolton-Maggs PHB. Idiopathic thrombocytopenic purpura. Arch. Dis. Child. 2000; 83: 220-22.
3. Mantadakis E, Buchanan GR. Elective splenectomy in children with idiopathic thrombocytopenic purpura. J. Pediatr. Hematol. Oncol. 2000; 22: 148-53.
4. George JN, Kojouri K, Perdue JJ, Vesely SK. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin. Hematol. 2000; 37: 290-98.
5. Di Gaetano N, Cittera E, Nota R et al. Complement activation determines the therapeutic activity of rituximab in vivo. J. Immunol. 2003; 171: 1581-7.
6. Patel K, Berman J, Ferber A, Caro J. Refractory autoimmune thrombocytopenic purpura treatment with rituximab. Am. J. Hematol. 2001; 67: 59-60.
7. Stasi R, Stipa E, Forte V, Meo P, Amadori S. Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenia purpura. Blood 2002; 99: 3872-3.
8. ten Cate R, Smiers FJ, Bredius RG et al. Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus. Rheumatology (Oxford) 2004; 43: 244.
9. Bengtson KL, Skinner MA, Ware RE. Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura. J. Pediatr. 2003; 143: 670-73.
10. Pusiol A, Cesaro S, Nocerino A, Picco G, Zanesco L, Bisogno G. Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia. Eur. J. Pediatr. 2004; 163: 305-7.